| Literature DB >> 8785455 |
M Adachi1, R Takayanagi, T Yanase, Y Sakai, S Ikuyama, H Nakagaki, Y Osamura, N Sanno, H Nawata.
Abstract
A 56-year-old male patient with cyclic Cushing's disease remained in a state of remission for more than one year with a relatively low dose of bromocriptine (2.5-3.75 mg/day). It has been reported that bromocriptine treatment for cyclic Cushing's disease induces only a transient remission; in the most effective cases, a relatively high dose (40 mg/day) was necessary. In the hypercortisolemic state, plasma adrenocorticotropic hormone (ACTH) and serum cortisol were not suppressed by dexamethasone and did not respond to corticotropin-releasing factor (CRF). An antehypophysectomy was not effective, even though the resected tissue contained ACTH-positive microadenomas. The present observations thus indicate the effectiveness of bromocriptine for some patients with this rare disorder.Entities:
Mesh:
Substances:
Year: 1996 PMID: 8785455 DOI: 10.2169/internalmedicine.35.207
Source DB: PubMed Journal: Intern Med ISSN: 0918-2918 Impact factor: 1.271